Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study - Fujii, Hiroaki; Nagakura, Hideyuki; Kobayashi, Nobuaki; Kubo, Sousuke; Tanaka, Katsushi; Watanabe, Keisuke; Horita, Nobuyuki; Hara, Yu; Nishikawa, Masanori; Miura, Kenji; Koizumi, Harumi; Ito, Yu; et al. (BMC cancer, 2022)
Keywords: Adrenal glands; Analysis; Antimitotic agents; Antineoplastic agents; Biopsy; Cancer therapies; Care and treatment; Cell-free deoxyribonucleic acid; Diagnosis; Disease; Dosage and administration; Enzyme inhibitors; Epidermal growth factor; Epidermal growth factor receptor; Epidermal growth factor receptors; Gene mutations; Health aspects; Liquid biopsy; Lung cancer; Lung cancer, Non-small cell; Lungs; Metastases; Metastasis; Mutation; Non-small cell lung cancer; Non-small cell lung carcinoma; Patients; Prevention; Protein-tyrosine kinase; Risk factors; Second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors; Small cell lung carcinoma; Survival analysis; Tumors; Japan; United States--US